Should You Buy Ichor Holdings Ltd (ICHR) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/29
ICHR is not a good buy right now for a Beginner, long-term investor with $50k–$100k who is impatient. The chart is still bullish (strong moving-average stack), but momentum is cooling near ~$30–$31 and the fundamental picture shows improving revenue but severely compressed gross margins. With earnings coming on 2026-02-09 and recent Wall Street caution (notably Oppenheimer’s downgrade citing “little margin for error”), the risk/reward at the current price looks unattractive versus waiting for either a pullback toward support or a cleaner margin recovery signal.
Technical Analysis
Price is around $30.49 (near the pivot 30.368). Trend remains bullish: SMA_5 > SMA_20 > SMA_200 indicates an established uptrend. MACD histogram is positive (0.232) but positively contracting, suggesting upside momentum is weakening rather than accelerating. RSI(6) ~64 is neutral-to-warm (not overbought), so there is room to move higher, but it’s not a strong “fresh breakout” setup. Key levels: Support S1 ~27.17 (then 25.20), Resistance R1 ~33.57 (then 35.54). Near-term probabilistic trend data implies modest upside over the next week but a slightly negative tilt over the next month.
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock today.
Analyst Ratings and Price Target Trends
Recent trend is mixed with a slight cooling after the rally: Needham upgraded to Buy with a $36 target (2026-01-20), B. Riley stayed Neutral but lifted target to $30 (2026-01-21), and Oppenheimer downgraded to Perform while nudging target to $32 (2026-01-27), explicitly arguing the stock now leaves limited margin for error. Wall Street pros: improving industry/memory-cycle demand and potential margin expansion under new leadership. Cons: execution and manufacturing-ramp history, transition-year dynamics, and concerns that much of the upside is already priced in.
Wall Street analysts forecast ICHR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ICHR is 24.8 USD with a low forecast of 21 USD and a high forecast of 30 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast ICHR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ICHR is 24.8 USD with a low forecast of 21 USD and a high forecast of 30 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 30.880
Current: 30.880
